Compounds > diacerein
Page last updated: 2024-08-22

diacerein and EBS-DM

diacerein has been researched along with EBS-DM in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ablinger, M; Bauer, JW; Brunner, V; Buckova, H; Diem, A; Felder, TK; Hitzl, W; Hofbauer, P; Hovnanian, A; Kitzmüller, S; Lagler, FB; Laimer, M; Lettner, T; Ly, J; Wally, V; Wolkersdorfer, M1
Ablinger, M; Bauer, JW; Diem, A; Felder, TK; Hofbauer, P; Lagler, FB; Lettner, T; Wally, V; Wimmer, M; Wolkersdorfer, M; Zauner, R1
Coleman, K; Limmer, AL; Mui, UN; Nwannunu, CE; Patel, RR; Shah, R; Tyring, SK1
Bauer, JW; Diem, A; Dornauer, M; Eiler, N; Felder, TK; Hitzl, W; Hofbauer, P; Kitzmueller, S; Lagler, F; Moder, A; Wally, V; Wolkersdorfer, M1
Bauer, JW; Hainzl, S; Hintner, H; Lettner, T; Murauer, EM; Peckl-Schmid, D; Peking, P; Wally, V1

Reviews

1 review(s) available for diacerein and EBS-DM

ArticleYear
Topical Diacerein Ointment for Epidermolysis Bullosa Simplex: A Review
    Skin therapy letter, 2019, Volume: 24, Issue:3

    Topics: Administration, Cutaneous; Anthraquinones; Anti-Inflammatory Agents; Epidermolysis Bullosa Simplex; Humans

2019

Trials

3 trial(s) available for diacerein and EBS-DM

ArticleYear
Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial.
    Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:5

    Topics: Administration, Topical; Anthraquinones; Anti-Inflammatory Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Epidermolysis Bullosa Simplex; Female; Follow-Up Studies; Humans; Male; Orphan Drug Production; Patient Compliance; Risk Assessment; Severity of Illness Index; Treatment Outcome

2018
Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex.
    Orphanet journal of rare diseases, 2018, 11-01, Volume: 13, Issue:1

    Topics: Administration, Topical; Anthraquinones; Anti-Inflammatory Agents; Epidermolysis Bullosa Simplex; Humans; Male; Molecular Structure

2018
Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study.
    Orphanet journal of rare diseases, 2013, May-07, Volume: 8

    Topics: Administration, Topical; Adolescent; Adult; Anthraquinones; Anti-Inflammatory Agents; Blister; Child; Double-Blind Method; Epidermolysis Bullosa Simplex; Humans; Keratin-14; Middle Aged; Pilot Projects; Treatment Outcome; Young Adult

2013

Other Studies

1 other study(ies) available for diacerein and EBS-DM

ArticleYear
The pathogenetic role of IL-1β in severe epidermolysis bullosa simplex.
    The Journal of investigative dermatology, 2013, Volume: 133, Issue:7

    Topics: Alleles; Anthraquinones; Anti-Inflammatory Agents; Antibodies; Cells, Cultured; Epidermolysis Bullosa Simplex; Humans; Interleukin-1beta; Keratin-14; Keratinocytes; MAP Kinase Signaling System; Mutation; Severity of Illness Index; Signal Transduction

2013